Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Whole body application of a potent topical corticosteroid for bullous pemphigoid.

Terra JB, Potze WJ, Jonkman MF.

J Eur Acad Dermatol Venereol. 2014 Jun;28(6):712-8. doi: 10.1111/jdv.12153. Epub 2013 Apr 3.

PMID:
23551654
2.

The role of topical corticosteroids in bullous pemphigoid in the elderly.

Joly P, Fontaine J, Roujeau JC.

Drugs Aging. 2005;22(7):571-6. Review.

PMID:
16038572
3.

Treatment of bullous pemphigoid.

Fontaine J, Joly P, Roujeau JC.

J Dermatol. 2003 Feb;30(2):83-90. Review.

PMID:
12692373
4.

[Bullous pemphigoid: a review].

Bernard P, Charneux J.

Ann Dermatol Venereol. 2011 Mar;138(3):173-81. doi: 10.1016/j.annder.2011.01.004. Epub 2011 Feb 16. Review. French.

PMID:
21397147
5.

Interventions for bullous pemphigoid.

Kirtschig G, Middleton P, Bennett C, Murrell DF, Wojnarowska F, Khumalo NP.

Cochrane Database Syst Rev. 2010 Oct 6;(10):CD002292. doi: 10.1002/14651858.CD002292.pub3. Review.

PMID:
20927731
6.

Topical class I corticosteroids in 10 patients with bullous pemphigoid: correlation of the outcome with the severity degree of the disease and review of the literature.

Stockman A, Beele H, Vanderhaeghen Y, Naeyaert JM.

J Eur Acad Dermatol Venereol. 2004 Mar;18(2):164-8. Review.

PMID:
15009295
7.

Iatrogenic Cushing's syndrome and topical steroid therapy: case series and review of the literature.

Decani S, Federighi V, Baruzzi E, Sardella A, Lodi G.

J Dermatolog Treat. 2014 Dec;25(6):495-500. doi: 10.3109/09546634.2012.755252. Epub 2013 Feb 3. Review.

PMID:
23210698
8.

Interventions for bullous pemphigoid.

Khumalo N, Kirtschig G, Middleton P, Hollis S, Wojnarowska F, Murrell D.

Cochrane Database Syst Rev. 2005 Jul 20;(3):CD002292. Review. Update in: Cochrane Database Syst Rev. 2010;(10):CD002292.

PMID:
16034874
9.

Interventions for bullous pemphigoid.

Khumalo N, Kirtschig G, Middleton P, Hollis S, Wojnarowska F, Murrell D.

Cochrane Database Syst Rev. 2003;(3):CD002292. Review. Update in: Cochrane Database Syst Rev. 2005;(3):CD002292.

PMID:
12917929
10.

Evaluation of the safety and efficacy of a potent topical cortico-steroid in the treatment of bullous pemphigoid.

Claudy A.

Clin Dermatol. 2001 Nov-Dec;19(6):778-80. Review. No abstract available.

PMID:
11705688
11.

Bullous pemphigoid: from bench to bedside.

Walsh SR, Hogg D, Mydlarski PR.

Drugs. 2005;65(7):905-26. Review.

PMID:
15892587
12.

Management of bullous pemphigoid: recommendations for immunomodulatory treatments.

Kirtschig G, Khumalo NP.

Am J Clin Dermatol. 2004;5(5):319-26. Review.

PMID:
15554733
13.

Bullous pemphigoid in a renal transplant recipient: a case report and review of the literature.

Chen TJ, Lai PC, Yang LC, Kuo TT, Hong HS.

Am J Clin Dermatol. 2009;10(3):197-200. doi: 10.2165/00128071-200910030-00007. Review.

PMID:
19354335
14.

Topical interventions for genital lichen sclerosus.

Chi CC, Kirtschig G, Baldo M, Brackenbury F, Lewis F, Wojnarowska F.

Cochrane Database Syst Rev. 2011 Dec 7;(12):CD008240. doi: 10.1002/14651858.CD008240.pub2. Review.

PMID:
22161424
15.

Treatments of choice for bullous pemphigoid.

Cooper SM, Wojnarowska F.

Skin Therapy Lett. 2002 Jan;7(1):4-6. Review.

PMID:
11859388
16.

[Topical corticosteroids and corticosteroid sparing therapy in psoriasis management].

Sukarovska BG, Lipozencić J, Vrzogić P.

Acta Med Croatica. 2007 Sep;61(4):375-81. Review. Croatian.

PMID:
18044472
18.

Clobetasol propionate emollient formulation foam in the treatment of corticosteroid-responsive dermatoses.

Frangos JE, Kimball AB.

Expert Opin Pharmacother. 2008 Aug;9(11):2001-7. doi: 10.1517/14656566.9.11.2001 . Review.

PMID:
18627337

Supplemental Content

Support Center